Retinoblastoma, or cancer of the eye is a type of cancer most common in toddlers. Children Polyclinic Hematology / Oncology RSCM noted retinablastoma least 15-22 patients who come with an age range three months to seven years.

Doctors Eye Specialist Eye Aini Hospital, dr. Lumongga Simangunsong, SpM (K) said more than 30% of people who come retinablastoma it was in an advanced stage with the characteristics of dilated eyes and stuck out.

“Cancer cure rate is not dependent stage tumors. If the tumor is still confined within the eyeball, aka still early, cure rates can reach 100%, but when it’s expanded, or in an advanced stage may be 0-50%, “said lumongga the Child Cancer Seminar organized by the Child Cancer Foundation Love Indonesia (YKAKI ) on Campus Institute of Science and Technology Agency (ISTN) Jakarta, Wednesday (26 / 3).

The definition of cure rate reached 100% means that doctors do not have to lift the patient’s eyeball retinablastoma. However, if it is severe, difficult to maintain the patient’s eyes, even life threatening sufferers. Lumongga acknowledged difficulties retinablastoma early detection. The symptoms are very similar to other eye diseases.

“It’s a bit difficult diagnosed early. But if there is such a small stain and a clear eye on the ball, it should really pay attention as the tumor is still small and immediately go to the doctor, “said lumongga.

In addition to detecting transparent stain on eyeball, retinablastoma symptoms can also be known if the boy’s eyes squint (strabismus) or the right and left eye is not on the same focus.

“Yes, if children aged under five years were cross-eyed, be careful. Try examined. But not all eyes that squint eye indicates the cancer, “added lumongga.

At an advanced stage, malignant eye cancer will continue to grow through the eyeball and into the orbita or the eye socket bone to stick out. If the cancer continued to spread, can spread to vital organs in the vicinity, such as the bone, into the brain through the nerves, the spinal cord and lymph nodes. At this stage, the child’s life chances is difficult to fight.


For several years the survival of the Tasmanian Devil (Tasmanian devil) threatened attack deadly cancer. Its cause is unknown and researchers continue to try to prevent the extinction.

As typical of other Australian animals, animals with a species name also Sarcophilus harrisii marsupial species. Females have a pouch on his stomach to keep and feed her newborn yag. Currently the Tasmanian Devil lives only in Tasmania, but fossil evidence indicates that these animals never lived in mainland Australia.

Besides bags, the Tasmanian Devil also has a characteristic thick black hair all over her body. Behavior is also typical of the strong-smelling gas out against the enemy, shrill voice, and match the fearsome teeth when crushed prey.

Since the 1800s, the settlers hunted these animals for attacking livestock. We have not a man who became the main threat, but a malignant tumor front. The disease is transmitted through the bite. Usually attacked 2-year-old animals and can cause death within months.

Before the disease breaks out, the average age in the population over 3 years. However, this time the animals are sexually mature in under a year rises to 13-83 percent. This is the result of measurements taken Menna Jones and other researchers from the University of Tasmania at the four points of the population.

The researchers speculate that changes in population distribution and decreased competition for food animals to encourage the young to reproduce before their time. The earlier breeding may be a solution that was developed Tasmanian devil populations to adapt to attack cancer. Mammals of Tasmania’s unique island to fight to change their sexual strategy to deal with the situation.

Cancer that attacks the mouth, face, and neck was first reported in 1996 in one of the Tasmanian devil population centers. In 2007, the disease is spread to more than half the population distribution. As a result of the disease, the population declined nearly 89 percent.


UNDER International Data for Research on Center (IARC), 1 in 600 children in the world will suffer from cancer before the age of 16 years. Indeed, the magnitude of the rate of child cancer patients ranged between 1% -3% of the total number of cancer patients, but the child cancer specialist from RSCM, dr. Maria Abdulsalam, Sp.A (K) said the success of treatment for child cancer is relatively high if treated early-stage start.

Maria explained the number of cancer-free survival in children at an early stage reached 90% whereas in advanced stage only about 20% -40%.

“The boy was still growing and growing. So if treated early on, the possibility of recovery is enormous. But on the part of the RSCM course, patients who come with advanced stage were more than 60%, “said Mary in Child Cancer Seminar organized by Yayasan Kasih Anak Kanker Indonesia (YKAKI) on Campus Institute of Science and Technology Agency (ISTN) Jakarta, Wednesday (26 / 3).

Cancer on their own children can be caused by two factors, namely genetic factors and environmental factors. Genetic factors are inherited factors from the father or mother’s family had a history of cancer. Environmental factors are external factors that cause cancer potential, such as the influence of chemicals, light radiation, the use of drugs, viral infections and diet.

“For environmental factors, we can control this. For example, avoid foods that contain lots of dye. It’s often attract our children yes, because the colors is very attractive, “added Maria. child cancer specialists from RSCM, dr. Mary Abdulsalam, Sp.A (K)

According to Maria too, kind of the most common cancer suffered by children is a blood cancer (leukemia), colon cancer, brain cancer, eye cancer (retinablastomata) and nerve cancer.

“Cancer is most common in children’s leukemia, it reached 60% -75% of the total cases. Next colon cancer, brain cancer, and cancer retinablastomata nerves, “he said.

For that, Mary said to alert parents to changes that occur in children and immediately went to the doctor to consult.

“Think of cancer when they saw or felt a lump in the child’s body. Not all lumps were cancerous. Then if you feel a lump, go directly to the doctor. Do not be pressured-press, will be spread, from stage 1 stage 2 even so, “said Maria on initial strategies to detect cancer in children.
Contribute a better translation

Male Breast Cancer

Cancer February 24th, 2010

kanker-payudara-pria

Description
Breast cancer is not only experienced by women, men also have breast tissue that can undergo cancerous. Breast cancer men attacked the most common male 60-70 years of age. Although male breast cancer and breast cancer in women similar, important differences such as the breast lies in the size and awareness affect early diagnosis and survival in breast cancer cases men.

Symptoms
Knowing the signs and symptoms of breast cancer can help save lives. The earlier this disease is found, the more treatment options and better opportunities.

The most common sign of breast cancer for men and women is a lump or thickening in the breast. Often the lump is painless. Symptoms of male breast cancer include:
* The skin dimpling or wrinkling
* Development of new or revocation of the curve of the nipple
* Changes in skin of the nipple or breast, such as scaling or redness

Treatment
Breast cancer in men are generally treated the same as in women. In most cases there is no proper treatment there. On the other hand, will want to find the best approach. To do so, should consider various factors, including cancer stage and age.

Vaccines for cancer cells

Cancer December 12th, 2009

vaksin-CML-dalam-topnews
cancer treatment still leaves some cancer cells in the body that are not killed. Now there is a vaccine to eliminate cancer cells that remained in the patients, especially chronic myeloid leukemia (chronic myeloid leukemia / CML).

This vaccine can help some patients with CML who took the drug Gleevec. But the researchers revealed that the results of this research is still tentative or not yet reached the final.

This research is funded by the National Institutes of Health and led by Dr. Hyam Levitsky, a professor yaiu oncology, medicine and urology from the Johns Hopkins Kimmel Cancer Center in Baltimore, Maryland. The results of this research has appeared in the journal Clinical Cancer Research.

Gleevec drug marketed by Novartis as Gleevec in the U.S. and Glivec in Europe and Australia, is one of the targeted cancer drugs successfully treat patients with CML.

These drugs are destroying most of the cancer cells, but for certain patients the cancer cells can still be detected by using a sensitive molecular test. The remaining cancer cells can cause the growth of the cancer returning.

Researchers explain the majority of patients with CML in the Gleevec should consume most of his life, although approximately 90 percent of patients get relief. But about 10-15 percent of patients can not tolerate for long-term use.

Levitsky disclose this vaccine is made to shine CML cells that do not turn into cancer. After that change the genetic material of these cells to produce immune system stimulators known as GM-CSF (granulocyte-macrophage colony-stimulating factor) is a substance that can help make white blood cells a particular type.

These cells will also carry antigens that would destroy the CML cells are still circulating in the body. Researchers involving 19 CML patients who were given the vaccine. All patients measured by its level of CML cells and have been taking Gleevec for more than 12 months. Patients are given the vaccine with 4 times the chance of 10 shots in every opportunity.

Cells acquired the remaining cancer has decreased, ie 12 patients found to reach the lowest levels of the cancer cells remaining, and 7 other people is not detected at all remaining cancer cells in the body.

But the researchers realized that the study is still limited, such as the limited number of patients and the lack of comparison with other therapies.

Because it still needs further research to ensure that this vaccine can actually lower the cancer cells that remain. The test was conducted also show side effects such as pain at the injection site, swelling, sometimes pain in the muscles and a mild fever.

blank